Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Taking peritoneal dialysis beyond the year 2000.

R Gokal1

  • 1Department of Renal Medicine, Manchester Royal Infirmary, United Kingdom.

Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis
|August 5, 1999
PubMed
Summary

Peritoneal dialysis (PD) now offers patient survival rates comparable or superior to hemodialysis. Future advancements in PD focus on personalized prescriptions and biocompatible solutions for improved patient outcomes and cost-effectiveness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of pregnancy following renal transplantation.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology·2004
Same author

Bacillus circulans peritonitis in a patient treated with CAPD.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2004
Same author

End-stage renal disease in Indo-Asians in the North-West of England.

QJM : monthly journal of the Association of Physicians·2003
Same author

Treatment of infections in peritoneal dialysis.

Contributions to nephrology·2003
Same author

Peritoneal dialysis as the first-choice treatment.

Contributions to nephrology·2003
Same author

Side-effects of antituberculosis drug treatment in patients with chronic renal failure.

The European respiratory journal·2002

Area of Science:

  • Nephrology
  • Renal Replacement Therapy
  • Dialysis Technology

Background:

  • Peritoneal dialysis (PD) has demonstrated significant advancements over the past 25 years.
  • Patient survival outcomes with PD are now equivalent to, and sometimes exceed, those of hemodialysis.
  • Improved understanding of peritoneal membrane pathophysiology and prescription optimization is key.

Purpose of the Study:

  • To review the advancements in peritoneal dialysis over the last 25 years.
  • To discuss the future trends and potential improvements in PD therapy.
  • To highlight the benefits of PD including patient survival, lifestyle, and cost-effectiveness.

Main Methods:

  • Review of existing literature and clinical data on peritoneal dialysis outcomes.

Related Experiment Videos

  • Analysis of trends in PD prescription, technology, and solution development.
  • Comparison of PD outcomes with hemodialysis.

    • Main Results:

    • Peritoneal dialysis (PD) now achieves patient survival rates comparable or superior to hemodialysis.
    • Optimized PD prescriptions and a better understanding of membrane function are crucial for success.
    • Automated PD and earlier initiation of dialysis are emerging trends.
    • Newer solutions like icodextrin facilitate long-dwell PD and incremental approaches.
    • Future PD solutions aim for enhanced biocompatibility, nutrition, and cardiovascular benefits.
    • PD is more cost-effective than in-centre hemodialysis.

    Conclusions:

    • Peritoneal dialysis (PD) has evolved into a highly effective renal replacement therapy.
    • Early initiation and personalized prescriptions are recommended for optimal PD outcomes.
    • Advancements in PD technology and solutions promise further improvements in patient care and cost-efficiency.
    • PD is increasingly becoming a preferred first-choice therapy for end-stage renal disease.